These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The histamine H3 receptor as a therapeutic drug target for CNS disorders.
    Author: Gemkow MJ, Davenport AJ, Harich S, Ellenbroek BA, Cesura A, Hallett D.
    Journal: Drug Discov Today; 2009 May; 14(9-10):509-15. PubMed ID: 19429511.
    Abstract:
    The histamine H3 receptor plays a regulatory role in the pre-synaptic release of histamine and other neurotransmitters, making it an attractive target for CNS indications including cognitive disorders, narcolepsy, ADHD and pain. As more and more H3 antagonists/H3 inverse agonists progress through the clinic, knowledge is gained to define the profile of the 'ideal' compound in terms of specificity, pharmacokinetic parameters and both duration and magnitude of receptor occupancy. Whether a single compound profile for the treatment of different disorders can be defined remains to be seen.
    [Abstract] [Full Text] [Related] [New Search]